Subscriber: th..@boehringer-ingelheim.com
HIV Infection
25 September 2017 | n=0
Display articles in
|
 |
|
Amedeo HIV Infection
Data Origin
You selected the following journals for your Amedeo HIV Infection newsletter:
AIDS, AIDS Res Hum Retroviruses, Ann Intern Med, BMJ, Clin Infect Dis, J Acquir Immune Defic Syndr, J Clin Immunol, J Clin Invest, J Infect Dis, J Med Virol, J Virol, JAMA, Lancet, N Engl J Med, Nat Med, Pediatr Infect Dis J, Science, Virology.
To modify the journal selection, please open your Newsletter Management Page. If you don't remember the URL, please submit the email address of your Amedeo subscription.
|
|
|
|
Amedeo HIV Infection
Five-Week Literature
|
|
|
|
25 September 2017
Multidisciplinary Journal Club
- Xie YL, Chakravorty S, Armstrong DT, Hall SL, et al.
Evaluation of a Rapid Molecular Drug-Susceptibility Test for Tuberculosis.
N Engl J Med. 2017;377:1043-1054.
- Wolchok JD, Chiarion-Sileni V, Gonzalez R, Rutkowski P, et al.
Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma.
N Engl J Med. 2017 Sep 11. doi: 10.1056/NEJMoa1709684.
- Weber J, Mandala M, Del Vecchio M, Gogas HJ, et al.
Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma.
N Engl J Med. 2017 Sep 10. doi: 10.1056/NEJMoa1709030.
Every week, Amedeo's Multidisciplinary Journal Club (MJC) presents a selection of outstanding articles. Take a look beyond the horizon.
|
|
|
|
